Comments
Pharma group urges broader U.S. market approach to Medicare
21.09.2012. | WASHINGTON (Reuters) - The role of the U.S. pharmaceutical industry within Medicare should be expanded as a way to reduce the popular healthcare program's contribution to the federal deficit without resorting to drug rebates, the chief of the industry's trade group said on Thursday....
